These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 10446867

  • 1. Correlation of increased susceptibility to apoptosis of CD4+ T cells with lymphocyte activation and activity of disease in patients with primary Sjögren's syndrome.
    Zeher M, Szodoray P, Gyimesi E, Szondy Z.
    Arthritis Rheum; 1999 Aug; 42(8):1673-81. PubMed ID: 10446867
    [Abstract] [Full Text] [Related]

  • 2. Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression.
    Gougeon ML, Lecoeur H, Dulioust A, Enouf MG, Crouvoiser M, Goujard C, Debord T, Montagnier L.
    J Immunol; 1996 May 01; 156(9):3509-20. PubMed ID: 8617980
    [Abstract] [Full Text] [Related]

  • 3. [Cell-mediated immunity in patients with Sjogren's syndrome].
    Krejsek J, Slezák R, Kopecký O, Vokurková D, Loudová M, Derner V.
    Cas Lek Cesk; 1997 Jan 22; 136(2):44-7. PubMed ID: 9147852
    [Abstract] [Full Text] [Related]

  • 4. Development of autoimmune arthritis with aging via bystander T cell activation in the mouse model of Sjögren's syndrome.
    Kobayashi M, Yasui N, Ishimaru N, Arakaki R, Hayashi Y.
    Arthritis Rheum; 2004 Dec 22; 50(12):3974-84. PubMed ID: 15593201
    [Abstract] [Full Text] [Related]

  • 5. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
    Fauchais AL, Boumediene A, Lalloue F, Gondran G, Loustaud-Ratti V, Vidal E, Jauberteau MO.
    Scand J Rheumatol; 2009 Dec 22; 38(1):50-7. PubMed ID: 18830907
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Suppression of human B cell responsiveness by CD4+ T cells does not involve CD95-CD95 ligand interactions.
    Hirohata S.
    Cell Immunol; 1997 Nov 01; 181(2):182-91. PubMed ID: 9398405
    [Abstract] [Full Text] [Related]

  • 11. CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome.
    Gottenberg JE, Lavie F, Abbed K, Gasnault J, Le Nevot E, Delfraissy JF, Taoufik Y, Mariette X.
    J Autoimmun; 2005 May 01; 24(3):235-42. PubMed ID: 15848046
    [Abstract] [Full Text] [Related]

  • 12. Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye.
    Stern ME, Gao J, Schwalb TA, Ngo M, Tieu DD, Chan CC, Reis BL, Whitcup SM, Thompson D, Smith JA.
    Invest Ophthalmol Vis Sci; 2002 Aug 01; 43(8):2609-14. PubMed ID: 12147592
    [Abstract] [Full Text] [Related]

  • 13. Basis for defective proliferation of peripheral blood T cells to anti-CD2 antibodies in primary Sjögren's syndrome.
    Gerli R, Bertotto A, Agea E, Lanfrancone L, Cernetti C, Spinozzi F, Rambotti P.
    J Clin Invest; 1990 Dec 01; 86(6):1870-7. PubMed ID: 1979333
    [Abstract] [Full Text] [Related]

  • 14. Immunohistologic analysis of lymphoid infiltrates in primary Sjogren's syndrome using monoclonal antibodies.
    Adamson TC, Fox RI, Frisman DM, Howell FV.
    J Immunol; 1983 Jan 01; 130(1):203-8. PubMed ID: 6600176
    [Abstract] [Full Text] [Related]

  • 15. Anti-CD95 (APO-1/Fas) autoantibodies and T cell depletion in human immunodeficiency virus type 1 (HIV-1)-infected children.
    Stricker K, Knipping E, Böhler T, Benner A, Krammer PH, Debatin KM.
    Cell Death Differ; 1998 Mar 01; 5(3):222-30. PubMed ID: 10200468
    [Abstract] [Full Text] [Related]

  • 16. T cell subpopulations in the labial minor salivary gland histopathologic lesion of Sjögren's syndrome.
    Skopouli FN, Fox PC, Galanopoulou V, Atkinson JC, Jaffe ES, Moutsopoulos HM.
    J Rheumatol; 1991 Feb 01; 18(2):210-4. PubMed ID: 1827160
    [Abstract] [Full Text] [Related]

  • 17. Apoptosis and Sjögren syndrome.
    Manganelli P, Fietta P.
    Semin Arthritis Rheum; 2003 Aug 01; 33(1):49-65. PubMed ID: 12920696
    [Abstract] [Full Text] [Related]

  • 18. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome.
    Diebold Y, Chen LL, Tepavcevic V, Ferdman D, Hodges RR, Dartt DA.
    Exp Eye Res; 2007 Mar 01; 84(3):500-12. PubMed ID: 17208228
    [Abstract] [Full Text] [Related]

  • 19. Lymphocyte subsets in Sjogren's syndrome: a quantitative analysis using monoclonal antibodies and the fluorescence-activated cell sorter.
    Bakhshi A, Miyasaka N, Kavathas P, Daniels TE, Strand CV, Herzenberg LA, Talal N.
    J Clin Lab Immunol; 1983 Feb 01; 10(2):63-9. PubMed ID: 6601716
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.